B. Metzler seel. Sohn & Co. AG Trims Position in Molina Healthcare, Inc $MOH

Key Points

• B. Metzler seel. Sohn & Co. AG reduced its stake in Molina Healthcare by 31.9%, now holding 3,403 shares valued at approximately $1,121,000.
• Analyst price targets for Molina Healthcare have been revised downwards, with Robert W. Baird setting a new target of $179.00 and JPMorgan lowering theirs to $184.00, both maintaining a "neutral" rating.
• Molina Healthcare's stock opened at $180.87, with a market cap of $9.80 billion and the company reported a quarterly revenue of $11.43 billion, exceeding analyst estimates.

B. Metzler seel. Sohn & Co. AG cut its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 31.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,403 shares of the company's stock after selling 1,595 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Molina Healthcare were worth $1,121,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Rothschild Investment LLC boosted its stake in Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after purchasing an additional 48 shares during the period. Zions Bancorporation National Association UT acquired a new stake in Molina Healthcare during the 1st quarter worth $29,000. Deseret Mutual Benefit Administrators boosted its stake in Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares during the period. Elequin Capital LP boosted its stake in Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after purchasing an additional 58 shares during the period. Finally, Colonial Trust Co SC boosted its stake in Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after purchasing an additional 93 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Price Performance

Shares of NYSE MOH traded down $7.86 on Thursday, hitting $169.19. The company's stock had a trading volume of 1,203,876 shares, compared to its average volume of 1,016,148. Molina Healthcare, Inc has a 12-month low of $151.95 and a 12-month high of $365.23. The company has a market capitalization of $9.17 billion, a price-to-earnings ratio of 8.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a 50 day moving average of $192.60 and a 200-day moving average of $271.34.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. During the same period last year, the company earned $5.86 EPS. The firm's revenue for the quarter was up 15.7% on a year-over-year basis. As a group, research analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MOH. UBS Group decreased their price objective on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Wall Street Zen cut Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Truist Financial restated a "hold" rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Wells Fargo & Company reduced their price target on Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a report on Friday, August 15th. Finally, Mizuho reduced their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Three research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $242.82.

Insiders Place Their Bets

In related news, COO James Woys purchased 10,000 shares of the business's stock in a transaction dated Monday, August 4th. The stock was bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. The trade was a 15.54% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.26% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.